Overexpression of FoxO3a in uremic hearts ameliorates pyroptosis and improves myocardial hypertrophy, interstitial fibrosis area and cardiac function, confirming that FoxO3a decrease is likely to be implied in the pathologic cardiac remodeling occurring in UCM as well [21]. The gene discussed is FOXO3; the disease is cardiac hypertrophy.